Literature DB >> 24297905

Regulation of Son of sevenless by the membrane-actin linker protein ezrin.

Katja J Geissler1, M Juliane Jung, Lars Björn Riecken, Tobias Sperka, Yan Cui, Stephan Schacke, Ulrike Merkel, Robby Markwart, Ignacio Rubio, Manuel E Than, Constanze Breithaupt, Sebastian Peuker, Reinhard Seifert, Ulrich Benjamin Kaupp, Peter Herrlich, Helen Morrison.   

Abstract

Receptor tyrosine kinases participate in several signaling pathways through small G proteins such as Ras (rat sarcoma). An important component in the activation of these G proteins is Son of sevenless (SOS), which catalyzes the nucleotide exchange on Ras. For optimal activity, a second Ras molecule acts as an allosteric activator by binding to a second Ras-binding site within SOS. This allosteric Ras-binding site is blocked by autoinhibitory domains of SOS. We have reported recently that Ras activation also requires the actin-binding proteins ezrin, radixin, and moesin. Here we report the mechanism by which ezrin modulates SOS activity and thereby Ras activation. Active ezrin enhances Ras/MAPK signaling and interacts with both SOS and Ras in vivo and in vitro. Moreover, in vitro kinetic assays with recombinant proteins show that ezrin also is important for the activity of SOS itself. Ezrin interacts with GDP-Ras and with the Dbl homology (DH)/pleckstrin homology (PH) domains of SOS, bringing GDP-Ras to the proximity of the allosteric site of SOS. These actions of ezrin are antagonized by the neurofibromatosis type 2 tumor-suppressor protein merlin. We propose an additional essential step in SOS/Ras control that is relevant for human cancer as well as all physiological processes involving Ras.

Entities:  

Keywords:  ERM proteins; GEF regulation; autoinhibition

Mesh:

Substances:

Year:  2013        PMID: 24297905      PMCID: PMC3870676          DOI: 10.1073/pnas.1222078110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Established and emerging fluorescence-based assays for G-protein function: Ras-superfamily GTPases.

Authors:  Rafael J Rojas; Randall J Kimple; Kent L Rossman; David P Siderovski; John Sondek
Journal:  Comb Chem High Throughput Screen       Date:  2003-06       Impact factor: 1.339

2.  Computational docking and solution x-ray scattering predict a membrane-interacting role for the histone domain of the Ras activator son of sevenless.

Authors:  Holger Sondermann; Bhushan Nagar; Dafna Bar-Sagi; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-02       Impact factor: 11.205

3.  Regulation of ras signaling dynamics by Sos-mediated positive feedback.

Authors:  Sean Boykevisch; Chen Zhao; Holger Sondermann; Polyxeni Philippidou; Simon Halegoua; John Kuriyan; Dafna Bar-Sagi
Journal:  Curr Biol       Date:  2006-11-07       Impact factor: 10.834

Review 4.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

Review 5.  ERM proteins: head-to-tail regulation of actin-plasma membrane interaction.

Authors:  S Tsukita; S Yonemura; S Tsukita
Journal:  Trends Biochem Sci       Date:  1997-02       Impact factor: 13.807

6.  Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway.

Authors:  A Aronheim; D Engelberg; N Li; N al-Alawi; J Schlessinger; M Karin
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

7.  The structural basis of the activation of Ras by Sos.

Authors:  P A Boriack-Sjodin; S M Margarit; D Bar-Sagi; J Kuriyan
Journal:  Nature       Date:  1998-07-23       Impact factor: 49.962

8.  Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase.

Authors:  C Herrmann; G A Martin; A Wittinghofer
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

9.  Ezrin, a key component in tumor metastasis.

Authors:  Kent W Hunter
Journal:  Trends Mol Med       Date:  2004-05       Impact factor: 11.951

10.  Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

Authors:  Marco Tartaglia; Len A Pennacchio; Chen Zhao; Kamlesh K Yadav; Valentina Fodale; Anna Sarkozy; Bhaswati Pandit; Kimihiko Oishi; Simone Martinelli; Wendy Schackwitz; Anna Ustaszewska; Joel Martin; James Bristow; Claudio Carta; Francesca Lepri; Cinzia Neri; Isabella Vasta; Kate Gibson; Cynthia J Curry; Juan Pedro López Siguero; Maria Cristina Digilio; Giuseppe Zampino; Bruno Dallapiccola; Dafna Bar-Sagi; Bruce D Gelb
Journal:  Nat Genet       Date:  2006-12-13       Impact factor: 38.330

View more
  11 in total

1.  An intimate look at LET-23 EGFR trafficking in the vulval cells of live C. elegans larvae.

Authors:  Juan M Escobar-Restrepo; Alex Hajnal
Journal:  Worm       Date:  2014-10-30

Review 2.  Role of Merlin/NF2 inactivation in tumor biology.

Authors:  A M Petrilli; C Fernández-Valle
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

3.  CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins.

Authors:  Lars Björn Riecken; Ansgar Zoch; Ulrike Wiehl; Sabine Reichert; Ingmar Scholl; Yan Cui; Mirjana Ziemer; Ulf Anderegg; Christian Hagel; Helen Morrison
Journal:  Oncotarget       Date:  2016-11-29

4.  Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44-/- tumor cells, MEFs and macrophages.

Authors:  Kristin Schultz; Christina Grieger Lindner; Yong Li; Pavel Urbánek; Anne Ruschel; Kerstin Minnich; Dunja Bruder; Marcus Gereke; Antonio Sechi; Peter Herrlich
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

5.  The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.

Authors:  Yan Cui; Susann Groth; Scott Troutman; Annemarie Carlstedt; Tobias Sperka; Lars Björn Riecken; Joseph L Kissil; Hongchuan Jin; Helen Morrison
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

6.  Decrease in membrane fluidity and traction force induced by silica-coated magnetic nanoparticles.

Authors:  Tae Hwan Shin; Abdurazak Aman Ketebo; Da Yeon Lee; Seungah Lee; Seong Ho Kang; Shaherin Basith; Balachandran Manavalan; Do Hyeon Kwon; Sungsu Park; Gwang Lee
Journal:  J Nanobiotechnology       Date:  2021-01-11       Impact factor: 10.435

7.  Novel mechanism of JNK pathway activation by adenoviral E1A.

Authors:  Vasily S Romanov; Anna I Brichkina; Helen Morrison; Tatiana V Pospelova; Valery A Pospelov; Peter Herrlich
Journal:  Oncotarget       Date:  2014-04-30

8.  Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.

Authors:  Yusuke Goto; Satoko Kojima; Akira Kurozumi; Mayuko Kato; Atsushi Okato; Ryosuke Matsushita; Tomohiko Ichikawa; Naohiko Seki
Journal:  Br J Cancer       Date:  2016-04-12       Impact factor: 7.640

9.  Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins.

Authors:  Nagham Asp; Audun Kvalvaag; Kirsten Sandvig; Sascha Pust
Journal:  Oncotarget       Date:  2016-05-03

10.  Silica-Coated Magnetic Nanoparticles Decrease Human Bone Marrow-Derived Mesenchymal Stem Cell Migratory Activity by Reducing Membrane Fluidity and Impairing Focal Adhesion.

Authors:  Tae Hwan Shin; Da Yeon Lee; Abdurazak Aman Ketebo; Seungah Lee; Balachandran Manavalan; Shaherin Basith; Chanyoung Ahn; Seong Ho Kang; Sungsu Park; Gwang Lee
Journal:  Nanomaterials (Basel)       Date:  2019-10-17       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.